Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome

Ann Neurol. 1997 Jul;42(1):68-73. doi: 10.1002/ana.410420112.

Abstract

Autoimmune damage to peripheral nerves, mediated by activated T lymphocytes and macrophages, underlies the pathogenesis of inflammatory demyelination in Guillain-Barré syndrome. Both T lymphocytes and macrophages secrete tumor necrosis factor-alpha, a cytokine that exerts toxic effects on myelin, Schwann cells, and endothelial cells. The reportedly high serum levels of this cytokine in patients with Guillain-Barré syndrome may reflect the degree of immune activation rather than a direct pathogenic effect. We compared serum levels of tumor necrosis factor-alpha, interleukin-1 beta, and soluble interleukin-2 receptor with well-established electrodiagnostic criteria for primary demyelination in 23 patients with Guillain-Barré syndrome, to assess the relationship between these cytokines and peripheral myelin damage. High serum levels of tumor necrosis factor-alpha were associated with prolonged distal motor latencies and slowed motor conduction velocities, prolonged or absent F-wave responses, and reduced amplitude of distal compound muscle action potentials. No significant correlation was observed between electrodiagnostic criteria for primary demyelination and serum levels of interleukin-1 beta or soluble interleukin-2 receptor. These findings suggest a putative role of tumor necrosis factor-alpha in the pathogenesis of peripheral nerve demyelination in Guillain-Barré syndrome.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Electrodiagnosis*
  • Female
  • Humans
  • Interleukin-1 / blood
  • Middle Aged
  • Osmolar Concentration
  • Polyradiculoneuropathy / blood*
  • Polyradiculoneuropathy / diagnosis*
  • Receptors, Interleukin-2 / blood
  • Solubility
  • Tumor Necrosis Factor-alpha / analysis*

Substances

  • Interleukin-1
  • Receptors, Interleukin-2
  • Tumor Necrosis Factor-alpha